| Dr Stacy Tamara Tarradath, MD | |
|
8501 Wilshire Blvd Ste 150, Beverly Hills, CA 90211-3148 | |
| (310) 248-7000 | |
| (310) 248-7033 |
| Full Name | Dr Stacy Tamara Tarradath |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 8501 Wilshire Blvd Ste 150, Beverly Hills, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053569095 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 278459 DUP (New York) | Secondary |
| 207Q00000X | Family Medicine | AAA4688 (California) | Primary |
| Entity Name | Healthcare Partners Affiliates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659312593 PECOS PAC ID: 7315842002 Enrollment ID: O20031204001258 |
News Archive
Columbia University scientists have developed a new optical technique to study how information is transmitted in the brains of mice. Using this method, they found that only a small portion of synapses - the connections between cells that control brain activity-may be active at any given time.
In healthy individuals, the amount of glucose, or sugar, in the blood increases after eating. When glucose increases, levels of insulin increase to carry the glucose to the rest of the body. Previous research has shown that extreme increases in glucose and insulin in the blood can lead to poor glucose control and increase an individual's risk of developing diabetes over time. Now, a University of Missouri researcher has found that when women consumed high-protein breakfasts, they maintained better glucose and insulin control than they did with lower-protein or no-protein meals.
Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
New results from a study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging. The findings may help identify those who would most benefit from early intervention.
› Verified 6 days ago
| Entity Name | Exer Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588901532 PECOS PAC ID: 9032359534 Enrollment ID: O20130705000153 |
News Archive
Columbia University scientists have developed a new optical technique to study how information is transmitted in the brains of mice. Using this method, they found that only a small portion of synapses - the connections between cells that control brain activity-may be active at any given time.
In healthy individuals, the amount of glucose, or sugar, in the blood increases after eating. When glucose increases, levels of insulin increase to carry the glucose to the rest of the body. Previous research has shown that extreme increases in glucose and insulin in the blood can lead to poor glucose control and increase an individual's risk of developing diabetes over time. Now, a University of Missouri researcher has found that when women consumed high-protein breakfasts, they maintained better glucose and insulin control than they did with lower-protein or no-protein meals.
Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
New results from a study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging. The findings may help identify those who would most benefit from early intervention.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stacy Tamara Tarradath, MD 3175 23rd St, Astoria, NY 11106-4134 Ph: (718) 956-2200 | Dr Stacy Tamara Tarradath, MD 8501 Wilshire Blvd Ste 150, Beverly Hills, CA 90211-3148 Ph: (310) 248-7000 |
News Archive
Columbia University scientists have developed a new optical technique to study how information is transmitted in the brains of mice. Using this method, they found that only a small portion of synapses - the connections between cells that control brain activity-may be active at any given time.
In healthy individuals, the amount of glucose, or sugar, in the blood increases after eating. When glucose increases, levels of insulin increase to carry the glucose to the rest of the body. Previous research has shown that extreme increases in glucose and insulin in the blood can lead to poor glucose control and increase an individual's risk of developing diabetes over time. Now, a University of Missouri researcher has found that when women consumed high-protein breakfasts, they maintained better glucose and insulin control than they did with lower-protein or no-protein meals.
Jennerex, Inc., a clinical-stage biotherapeutics company focused on the development of first-in-class, targeted oncolytic products for cancer, today reported positive interim data from a pilot trial using JX-594 followed by sorafenib (Nexavar®) to treat liver cancer patients. The data were presented today at the Fourth Annual International Liver Cancer Association Conference in Montreal, Canada.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
New results from a study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging. The findings may help identify those who would most benefit from early intervention.
› Verified 6 days ago
Rajdeep Sandhu, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9301 Wilshire Blvd Ste 404, Beverly Hills, CA 90210 Phone: 310-278-9171 Fax: 310-278-2058 | |
Christina Vu Pham, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9725 Wilshire Blvd, Beverly Hills, CA 90212 Phone: 323-305-7150 | |
Dr. Marvin Berkowitz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 614 N Roxbury Dr., Beverly Hills, CA 90210 Phone: 310-276-8211 | |
Marcus Alberto Tellez, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 150 N Robertson Blvd Ste 300, Beverly Hills, CA 90211 Phone: 310-652-2562 | |
Dr. Daniella Abigail Newman, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 9150 Wilshire Blvd, Ste 101, Beverly Hills, CA 90212 Phone: 310-888-8877 | |
Dr. Candice C Lee Kit, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 8767 Wilshire Blvd Fl 3, Beverly Hills, CA 90211 Phone: 310-385-6031 |